Plain-English translation of NCT07267117 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that tracks patients with heart valve disease across 15 major hospitals in China. Researchers want to understand how valve problems progress over time, which patients are at highest risk, and how different treatments affect outcomes. By following you over the years with regular checkups and heart imaging, doctors hope to find early warning signs and develop better treatment strategies.
Right now, doctors don't have clear guidelines for managing patients with moderate valve disease, and it's hard to predict who will get worse and how quickly. This study exists to find the early signs that help doctors catch problems before they become serious, and to learn which treatments help patients live better lives.
You likely qualify if…
You likely don't qualify if…
After joining the study, you will visit your doctor once a year for follow-up appointments. At each visit, you'll have an electrocardiogram (heart electrical test), a heart ultrasound, blood tests, and possibly a CT scan with contrast dye. These tests help researchers track how your valve disease is changing and identify warning signs early. The study is purely observational—you're not being asked to take a new medication, but rather to allow doctors to monitor you carefully over time.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China